- In March 2024, AstraZeneca completed the acquisition of Fusion Pharmaceuticals, aiming to accelerate advancements in cancer treatment. This acquisition is focused on shifting away from conventional therapies such as chemotherapy and radiotherapy, towards more innovative and targeted approaches that enhance patient outcomes
- In January 2024, GE HealthCare acquired MIM Software, a company specializing in AI-driven imaging and workflow solutions. This acquisition enables GE HealthCare to integrate MIM’s advanced AI-enabled tools into sectors such as oncology and neurology, enhancing diagnostic accuracy and improving treatment planning across these critical healthcare domains
